1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology Analysis & Statistics, October 2016 (p50)

Biotechnology Analysis & Statistics, October 2016 (p50)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Publishers

All regions

1471-1500 of about 7300 reports

Purchase Reports From Reputable Market Research Publishers

Iris BioTechnologies Inc. (IRSB) - Financial and Strategic SWOT Analysis Review

Iris BioTechnologies Inc. (IRSB) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary Iris BioTechnologies Inc. (Iris BioTechnologies) is a biotechnology company that develops and commercialize nano-biochips and artificial intelligence systems. The company’s products inlcude breast ...

  • Industries : Biotechnology
  • Countries : United States
Beijing Tiantan Biological Products Co., Ltd. (600161) - Financial and Strategic SWOT Analysis Review

Beijing Tiantan Biological Products Co., Ltd. (600161) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary Beijing Tiantan Biological Products Co., Ltd. (Tiantan Biological) a subsidiary of China National Pharmaceutical Group Corporation is a biotechnology company that research vaccines. The company ...

  • Industries : Biotechnology
  • Countries : China
Entest BioMedical Inc. (ENTB) - Financial and Strategic SWOT Analysis Review

Entest BioMedical Inc. (ENTB) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary Entest BioMedical Inc. (Entest BioMedical) is a biomedical research company that develops immuno-therapeutic treatments that address illnesses and maladies in both veterinary and human medicine. ...

  • Industries : Biopharmaceutical
ARCA biopharma, Inc. (ABIO) - Financial and Strategic SWOT Analysis Review

ARCA biopharma, Inc. (ABIO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary ARCA biopharma, Inc. (ARCA), formerly Nuvelo, Inc., is a biopharmaceutical company. The company focuses on the development of genetically targeted therapies for cardiovascular diseases. Its product ...

  • Industries : Biopharmaceutical
BB Biotech AG (BION) - Financial and Strategic SWOT Analysis Review

BB Biotech AG (BION) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary BB Biotech AG (BB Biotech) is an investment company that invests in biotechnology companies. The company invests in companies which concentrate on research and development of new drugs and therapies ...

  • Industries : Biotechnology
Protalix BioTherapeutics, Inc. (PLX) - Financial and Strategic SWOT Analysis Review

Protalix BioTherapeutics, Inc. (PLX) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary Protalix BioTherapeutics, Inc. (Protalix) is a biopharmaceutical company that develops and commercializes recombinant therapeutic proteins. The company provides elelyso, a plant cell-expressed ...

  • Industries : Biological Therapy
Can-Fite BioPharma Ltd. (CFBI) - Financial and Strategic SWOT Analysis Review

Can-Fite BioPharma Ltd. (CFBI) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary Can-Fite BioPharma Ltd. (Can-Fite) is a biopharmaceutical company that concentrates on the discovery and clinical development of drugs. The company's pipeline product portfolio comprise CF101, ...

  • Industries : Biopharmaceutical
International Stem Cell Corporation (ISCO) - Financial and Strategic SWOT Analysis Review

International Stem Cell Corporation (ISCO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary International Stem Cell Corporation (ISCC) is a biotechnology company that develops technology solutions. The company develops parthenogenesis, which is a stem cell technology that improves the ...

  • Industries : Biological Therapy
Level Biotechnology Inc. (3118) - Financial and Strategic SWOT Analysis Review

Level Biotechnology Inc. (3118) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary Level Biotechnology Inc (LBI) is a biotechnology company that offers molecular biology products and biomedical precision equipment. The company markets and distributes molecular biology products, ...

  • Industries : Biotechnology
Microbix Biosystems Inc. (MBX) - Financial and Strategic SWOT Analysis Review

Microbix Biosystems Inc. (MBX) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary Microbix Biosystems Inc. (Microbix) is a biotechnology company that develops biological products and technologies. The company’s products include infectious disease antigens, molecular diagnostic, ...

  • Industries : Biotechnology
Transgene SA (TNG) - Financial and Strategic SWOT Analysis Review

Transgene SA (TNG) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary Transgene SA (Transgene) is a biopharmaceutical company that discovers and develops pipeline of immunotherapies in the areas of cancer and infectious diseases. The company offers pipeline products ...

  • Industries : Genetically Modified Organism
XTL Biopharmaceuticals Ltd. (XTLB) - Financial and Strategic SWOT Analysis Review

XTL Biopharmaceuticals Ltd. (XTLB) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary XTL Biopharmaceuticals Ltd. (XTL) is a biopharmaceutical company that offers acquisition, development and commercialization of pharmaceutical products and formulations. The company’s pipeline ...

  • Industries : Biopharmaceutical
ChoongAng Vaccine Laboratory (072020) - Financial and Strategic SWOT Analysis Review

ChoongAng Vaccine Laboratory (072020) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary ChoongAng Vaccine Laboratory (CAVAC) is a healthcare company that offers animal biological products. The company manufactures and commercializes animal vaccines and diagnostic kits. Its product ...

  • Industries : Biopharmaceutical, Therapy
Shin Nippon Biomedical Laboratories, Ltd. (2395) - Financial and Strategic SWOT Analysis Review

Shin Nippon Biomedical Laboratories, Ltd. (2395) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary Shin Nippon Biomedical Laboratories, Ltd. (SNBL) is a healthcare service provider that provides drug and clinical development service to biopharmaceutical companies. Its preclinical services include ...

  • Industries : Biopharmaceutical
Japan Tissue Engineering Co., Ltd. (7774) - Financial and Strategic SWOT Analysis Review

Japan Tissue Engineering Co., Ltd. (7774) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary Japan Tissue Engineering Co., Ltd. (J-TEC) is a bio-venture company that develops, manufactures and sells tissue-engineered medical products and related products. The company's products include ...

  • Countries : Japan
Sunzen Biotech Berhad (SUNZEN) - Financial and Strategic SWOT Analysis Review

Sunzen Biotech Berhad (SUNZEN) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary Sunzen Biotech Berhad (Sunzen Biotech), a subsidiary of Pfizer Inc. is a manufacturer and distributor of animal health care products. The company provides animal health products that include feed ...

  • Industries : Biotechnology
Vitro Biopharma (VODG) - Financial and Strategic SWOT Analysis Review

Vitro Biopharma (VODG) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary Vitro Biopharma (Vitro) is a biopharmaceutical company that develops and commercializes adult stem cell. The company’s products include cell culture media, cell lines, and cell measurement tools. ...

  • Industries : Biopharmaceutical
Mavens Biotech Ltd (590083) - Financial and Strategic SWOT Analysis Review

Mavens Biotech Ltd (590083) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary Mavens Biotech Ltd (Mavens) is a biotechnology company that develops and validates plant technologies, which optimize crop performance and agricultural productivity. The company’s business units ...

  • Industries : Biotechnology
JiangXi ChangJiu Biochemical Industry Co., Ltd. (600228) - Financial and Strategic SWOT Analysis Review

JiangXi ChangJiu Biochemical Industry Co., Ltd. (600228) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary JiangXi ChangJiu Biochemical Industry Co., Ltd. (ChangJiu Biochemical) formerly Jiangxi Changjiu Chemicals Co., Ltd is a chemical company that manufactures and markets acrylamide crystals, pharm-chemicals, ...

  • Industries : Biotechnology
RegeneRx Biopharmaceuticals, Inc. (RGRX) - Financial and Strategic SWOT Analysis Review

RegeneRx Biopharmaceuticals, Inc. (RGRX) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary RegeneRx Biopharmaceuticals, Inc. (RegeneRx) is a biotechnology company that offers clinical stage drug development solutions. The company offers clinical trials, science and discovery and business ...

  • Industries : Biopharmaceutical
Genome Editing/Genome Engineering Market by Technology, Applications, End User - Global Forecast to 2021

Genome Editing/Genome Engineering Market by Technology, Applications, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The genome editing market is projected to reach USD 5.54 billion by 2021 from USD 2.84 billion in 2016, growing at a CAGR of 14.3% in the next five years (2016 to 2021). The genome editing market is undergoing ...

  • Industries : Biotechnology, Genomics
  • Countries : World
Applied Genetic Technologies Corporation (AGTC) - Financial and Strategic SWOT Analysis Review

Applied Genetic Technologies Corporation (AGTC) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary Applied Genetic Technologies Corporation (AGTC) is a pharmaceutical company that provides development of eye disease cures. The company develops treatments for patients that have diseases caused ...

  • Industries : Genomics
Global Biotechnology Reagent Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

Global Biotechnology Reagent Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

  • $ 3900
  • Industry report
  • October 2016
  • by Occams

"Global Biotechnology Reagent Market Research Report 2016" by OBRC, is an extensive study on present state of the biotechnology reagent market. The research report includes a basic outline of the industry ...

  • Industries : Biotechnology
  • Countries : World
Cell Biotech Co., Ltd. (049960) - Financial and Strategic SWOT Analysis Review

Cell Biotech Co., Ltd. (049960) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary Cell Biotech Co., Ltd. (Cell Biotech) is a biochemical company that manufactures and markets biochemical products. The company's products portfolio includes lactic acid bacteria (LAB) powders, ...

  • Industries : Biotechnology
Golden Biotechnology Corp. (4132) - Financial and Strategic SWOT Analysis Review

Golden Biotechnology Corp. (4132) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary Golden Biotechnology Corp. (Golden Biotech) is a biotechnology company that offers drug development programs. The company develops and commercializes drugs and herbal supplements to prevent and ...

  • Industries : Biotechnology
2016 Global Nucleic Acid Testing/NAT Market: Emerging Technologies and Strategic Profiles of Leading Suppliers

2016 Global Nucleic Acid Testing/NAT Market: Emerging Technologies and Strategic Profiles of Leading Suppliers

  • $ 3500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 180-page report provides detailed analyses of current and emerging molecular diagnostic technologies, and their potential market applications, including DNA sequencing, RNA probes, detection technologies, ...

  • Industries : Genomics
European Erythropoietin Market Outlook 2022

European Erythropoietin Market Outlook 2022

  • $ 1500
  • Industry report
  • October 2016
  • by RNCOS

Erythropoietin drugs are protein therapeutics, which is used to treat various types of anaemia. These drugs play a significant role in treating CKD related anaemia and cancer related anaemia. Since its ...

  • Industries : Biopharmaceutical
  • Countries : Europe
Global CRISPR/Cas9 Market Outlook 2022

Global CRISPR/Cas9 Market Outlook 2022

  • $ 1200
  • Industry report
  • October 2016
  • by RNCOS

The advent of CRISPR/Cas9 has revolutionized the Genome Editing Industry. This technique is allowing a previously unattainable level of genomic targeting with greater efficiency and simplicity. Due to ...

  • Industries : Biological Therapy
  • Countries : World, North America
Fortress Biotech, Inc. (FBIO) - Financial and Strategic SWOT Analysis Review

Fortress Biotech, Inc. (FBIO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary Fortress Biotech, Inc. (Fortress) formerly Coronado Biosciences, Inc. is a biopharmaceutical company that develops and commercializes pharmaceutical and biotechnology products. The company offers ...

  • Industries : Biotechnology
TCM Biotech International Corp (4169) - Financial and Strategic SWOT Analysis Review

TCM Biotech International Corp (4169) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary TCM Biotech International Corp (TCM Biotech) is a biotechnology company that researches, develops, manufactures and markets active pharmaceutical ingredient for new drug developments. The company ...

  • Industries : Biotechnology
About 36000 reports

Download Unlimited Documents from Trusted Public Sources

Global Therapy Market

  • January 2017
    32 pages
  • Therapy  

    Targeted Therap...  

    Monoclonal Anti...  

  • World  

View report >

Rna Industry In The Us

January 2017

Blood Supply Industry

January 2017

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.